Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 166
Infectious Diseases Drugs 125
Genomics 102
Liver and Kidney Disorders Drugs 69
Immune Disorders Drugs 60
Drug Discovery 55
Pharmaceuticals 53
Cardiovascular Drugs 47
Biopharmaceuticals 44
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 36
Clinical Trials 31
Lymphoma Drugs 30
Respiratory Drugs 29
Allergy and Immunology 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Pulmonary Medicine 23
Oncology 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 19
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Women's Health 7
Drugs by Therapeutic Area 6
Company Reports 5
Hepatology 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Generic Drugs 3
Prostate Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,042 Results (Page 27 of 53)
- Relevance
  Sort by

Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032

 Report
November 2023
353 Pages
Global

From

€6780EUR$7,600USD£5,930GBP

€8475EUR$9,500USD£7,413GBP

Immunology Market - Global Strategic Business Report

 Report
November 2025
374 Pages
Global

From

€5219EUR$5,850USD£4,565GBP

Antimicrobial Therapeutics Market 2024-2028

 Report
June 2024
175 Pages
Global

From

€2230EUR$2,500USD£1,951GBP

Global Biotechnology - Industry Market Research Report

 Report
April 2025
44 Pages
Global

€1075EUR$1,205USD£940GBP

MCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Insights 2025

 Report
July 2025
80 Pages
Global

From

€2319EUR$2,600USD£2,029GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cell & Gene Therapy Cold Chain Logistics Market Report 2025-2035

 Report
July 2025
422 Pages
Global

From

€5147EUR$5,972USD£4,350GBP

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4005EUR$4,490USD£3,504GBP

Pharmaceutical Drug Delivery Market by Route of Administration, by Application, Regional Outlook - Global Forecast up to 2030

 Report
July 2024
120 Pages
Global

From

€4014EUR$4,500USD£3,511GBP

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1427EUR$1,600USD£1,249GBP

€1784EUR$2,000USD£1,561GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1740EUR$1,950USD£1,522GBP

Ebola Drugs and Vaccines - Global Strategic Business Report

 Report
November 2025
485 Pages
Global

From

€5219EUR$5,850USD£4,565GBP

Chronic Lymphocytic Leukemia- Pipeline Insight, 2025

 Clinical Trials
April 2025
210 Pages
Global

From

€1784EUR$2,000USD£1,561GBP

€2230EUR$2,500USD£1,951GBP

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
925 Pages
Global

From

€2230EUR$2,500USD£1,951GBP

Autologous Stem Cell & Non-Stem Cell Therapies Market - Global Forecast 2025-2032

 Report
October 2025
188 Pages
Global

From

€3162EUR$3,545USD£2,766GBP

€3514EUR$3,939USD£3,074GBP

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
130 Pages
Global

From

€4014EUR$4,500USD£3,511GBP

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5674EUR$6,360USD£4,963GBP

€7092EUR$7,950USD£6,204GBP

Stem Cells Market - Global Forecast 2025-2032

 Report
November 2025
182 Pages
Global

From

€3162EUR$3,545USD£2,766GBP

€3514EUR$3,939USD£3,074GBP

Non-Viral Transfection Reagents Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Non-Viral Transfection Method, Application Areas, End-User, and Key Geographical Regions

 Report
September 2025
254 Pages
Global

From

€4281EUR$4,799USD£3,745GBP

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

 Report
February 2022
421 Pages
Global

From

€4281EUR$4,799USD£3,745GBP

Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5674EUR$6,360USD£4,963GBP

€7092EUR$7,950USD£6,204GBP

1,042 Results (Page 27 of 53)
- 1
- 25
- 26
- 27
- 28
- 29

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.